Loading...
Combination therapy with gemcitabine and nab-paclitaxel for locally advanced unresectable pancreatic cancer
The aim of the present study was to investigate the early treatment outcomes of combined gemcitabine and nab-paclitaxel treatment for locally advanced unresectable pancreatic cancer (LURPC). The subjects comprised 7 patients with LURPC receiving the abovementioned combination therapy at the Hirosaki...
Na minha lista:
| Udgivet i: | Mol Clin Oncol |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
D.A. Spandidos
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5451866/ https://ncbi.nlm.nih.gov/pubmed/28588798 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2017.1251 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|